Dr. Shannon Boye receives 2nd place prize in the 2013 ARVO Foundation/Merck Innovative Ophthalmology Research Award in Gene Therapy and Eye Disease

Selection was based upon her paper, “The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate Retina” by a panel of esteemed ARVO members who served as the judges. The award includes a $10,000 grant to Dr. Boye, complimentary Annual Meeting registration, reimbursement of airfare and hotel expenses for this year’s ARVO meeting and an invitation to the President’s Reception.